GENOMICS INDIA CONFERENCE – the 2 day extravaganza is coming close
Genomics India 2023, the 2- day extravaganza is here! A perfect amalgam of science and ideas that it is, our conference will discuss applications of...
Continue ReadingBiocon starts clinical trial of drug meant to treat Ulcerative Colitis in India
Biocon Limited announced the initiation of the clinical study of Itolizumab, a monoclonal antibody in patients with Ulcerative Colitis (UC) in India, in collaboration with...
Continue ReadingBiological E gets DCGI nod to market Pneumococcal Conjugate Vaccine in India
Hyderabad-based-Biological E. Limited (BE) announced that it has received marketing approval from the Drugs Controller General of India (DCGI) for its Pneumococcal Conjugate vaccine (PCV14)...
Continue ReadingDr Jagadeeshs Gouda, a renowned seed industry researcher has joined the management team of Yaganti Agrotech Pvt Ltd
Dr Jagadeeshs Gouda, a renowned seed industry researcher has joined the management team of Yaganti Agrotech Pvt Ltd ( BHARATI SEEDS ). Coming with more...
Continue ReadingGenomics India Conference is back after a three year gap!
Genomics India Conference is back after a three year gap! GIC, in 2023, is going to be bigger and better! We take immense pleasure in...
Continue ReadingCipla Gets CDSCO Panel Nod To Manufacture, Market FDC Tamsulosin Plus Solifenacin
Pharmaceutical major, Cipla has got a green signal from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) to manufacture...
Continue ReadingDr. Reddy’s Foundation receives national award for empowering persons with disabilities
Dr. Reddy’s Foundation has been conferred with the prestigious National Award for the Empowerment of Persons with Disabilities in New Delhi by Droupadi Murmu, President...
Continue ReadingMankind Pharma acquires majority stake in Upakarma Ayurveda
Pharmaceuticals giant Mankind Pharma Ltd. on otherday said it has acquired a majority stake in Upakarma Ayurveda Pvt Ltd through one of its subsidiaries for...
Continue ReadingCIPLA ANNOUNCES LAUNCH OF LEUPROLIDE ACETATE INJECTION DEPOT (22.5Mg)
Cipla announced the launch of Leuprolide Acetate Injection Depot 22.5mg. The product was approved by the United States Food and Drug Administration (‘US FDA’) based...
Continue Reading